...
首页> 外文期刊>Experimental and therapeutic medicine >Effects of simvastatin-loaded PLGA microspheres on treatment of rats with intervertebral disk degeneration and on 6-K-PGF1 alpha and HIF-1 alpha
【24h】

Effects of simvastatin-loaded PLGA microspheres on treatment of rats with intervertebral disk degeneration and on 6-K-PGF1 alpha and HIF-1 alpha

机译:辛伐他汀的PLGA微球对椎间盘变性大鼠和6-K-PGF1α和HIF-1α治疗大鼠的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Effects of simvastatin-loaded PLGA sustained release microspheres on the treatment of rats with intervertebral disk degeneration (IVDD) and on 6-keto-prostaglandin F1 alpha (6-K-PGF1 alpha) and hypoxia inducible factor-1 alpha (HIF-1 alpha) were investigated. Eighty female rats were selected and randomized into a model group (modeled for IVDD), a treatment group (modeled and treated with simvastatin-loaded PLGA sustained release microspheres), a sham operation group (only operated without excision), and a control group (not treated) (n=20 each). After modeling, 6-K-PGF1 alpha and HIF-1 alpha in the peripheral blood of the rats were, respectively, detected before simvastatin injection (T0), at 2 weeks (T1) and 4 weeks (T2) after simvastatin injection. The bone mineral density (BMD) of L-5 and L-6 was detected by X-ray. The trabecular thickness, number, and separation of the vertebral body were detected. Changes in the sagittal T2-weighted signal of intervertebral disc nucleus pulposus were detected by MRI. There were no differences between the control and sham operation groups in the indices (P>0.050). Compared with those in the model group during the treatment, BMD, 6-K-PGF1 alpha, HIF-1 alpha, and trabecular number in the treatment group significantly increased (P<0.050), while the trabecular separation significantly decreased (P<0.050). The sagittal T2-weighted MRI signal in the model group was the lowest between the four groups (P<0.050). Simvastatin-loaded PLGA sustained release microspheres can improve the BMD of the vertebral body and increase the contents of 6-K-PGF1 alpha and HIF-1 alpha in the treatment of rats with IVDD, so they are important for the clinical treatment of the disease.
机译:辛伐他汀加载的PLGA缓释微球对椎间盘退化(IVDD)和6-酮 - 前列腺素F1α(6-K-PGF1α)和缺氧诱导因子-1α(HIF-1α)治疗大鼠的影响)被调查了。选择八十雌性大鼠并随机分为模型组(为IVDD建模),治疗组(用辛伐他汀加载的PLGA持续释放微球进行建模和处理),假手术组(仅在没有切除的情况下操作)和对照组(未治疗)(每个n = 20)。在辛伐他汀注射(T0)之前,分别在大鼠外周血中检测到6-K-PGF1α和HIF-1α,在辛伐他汀注射后2周(T1)和4周(T2)之前,检测到6-K-PGF1α和HIF-1α。通过X射线检测L-5和L-6的骨矿物密度(BMD)。检测到椎体的小梁厚度,数量和分离。 MRI检测椎间盘髓核的矢状T2加权信号的变化。指数中的控制和假操作组之间没有差异(P> 0.050)。与在治疗期间的模型组中的那些相比,治疗组中的BMD,6-K-PGF1α,HIF-1α和小梁数显着增加(P <0.050),而小梁分离显着降低(P <0.050 )。模型组中矢状T2加权MRI信号是四组之间的最低(P <0.050)。辛伐他汀加载的PLGA持续释放微球可以改善椎体的BMD,并在治疗IVDD的大鼠治疗大鼠中增加6-K-PGF1α和HIF-1α的含量,因此对疾病的临床治疗是重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号